TELA Bio (TELA) Other Accumulated Expenses (2018 - 2026)

TELA Bio has reported Other Accumulated Expenses for 9 years, with the latest figure at $546000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 50.9% year-over-year to $546000.0; the trailing twelve-month figure through Mar 2026 stood at $546000.0 (down 50.9% YoY), and the FY2025 full-year result was $711000.0, up 48.43% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $546000.0, down from $711000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.2 million in Q2 2025, with the low at $51000.0 in Q1 2022.
• Average Other Accumulated Expenses over 5 years is $533588.2, with a median of $527000.0 recorded in 2023.
• Year-over-year, Other Accumulated Expenses sank 91.72% in 2022 and jumped 285.9% in 2024.
• Tracing TELA's Other Accumulated Expenses over 5 years: stood at $146000.0 in 2022, then soared by 260.96% to $527000.0 in 2023, then dropped by 9.11% to $479000.0 in 2024, then jumped by 48.43% to $711000.0 in 2025, then slipped by 23.21% to $546000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $546000.0 (Q1 2026), $711000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison